The 20 Best Autosomal Dominant Hypocalcemia Doctors Near Me in Ypsilanti, MI

Anuradha Puttagunta is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Puttagunta is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Nodule, and Hypothyroidism.

Suma Amarnath is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Amarnath is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Hyperthyroidism, Hypothyroidism, and Addison's Disease.

Anita Repp is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Repp is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Osteoporosis, Postmenopausal Osteoporosis, and Type 2 Diabetes (T2D).

Dhammi Jayathilaka is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Jayathilaka is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Thyroid Storm, Thyroid Nodule, Hyperthyroidism, and Hyperparathyroidism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Thyroidectomy, and Orchiectomy. Dr. Clines is board certified in Endocrinology, Diabetes & Metabolism.

Judith Mayer is a Nephrologist practicing medicine in Ypsilanti, Michigan. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Renovascular Hypertension, Chronic Kidney Disease, Nephrosclerosis, and Acute Tubular Necrosis.

Vidooshi Maru is a Nephrologist practicing medicine in Ypsilanti, Michigan. Dr. Maru is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Renovascular Hypertension, Nephrosclerosis, Acute Tubular Necrosis, and End-Stage Renal Disease (ESRD).

Jariatul Karim is a Nephrologist practicing medicine in Ypsilanti, Michigan. Dr. Karim is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Renovascular Hypertension, Nephrosclerosis, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD).

Dr. Heidelbaugh received his medical degree from Upstate Medical University at Syracuse in 1996, and completed his Family Practice residency at St. Joseph's Hospital Health Center, also in Syracuse, New York, in 1999. He is board-certified by the American Board of Family Medicine. He is the Director for the Third Year Required Clerkship. Dr. Heidelbaugh is actively involved in teaching both medical students and residents at Ypsilanti Health Center, and attends on the Department of Family Medicine's inpatient adult medicine at the University of Michigan Hospital. His clinical interests include gastroesophageal reflux disease (GERD) and other disorders of the gastrointestinal system; preventive health screening for men, women and children of all ages; chronic disease management; men's health, dermatologic procedures, and prenatal care. Dr. Heidelbaugh's practice encompasses patients of all ages, with a wide spectrum of both medical and psychosocial disease states.Dr. Heidelbaugh has a joint appointment in Family Medicine and Urology. Dr. Heidelbaugh is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hormone Replacement Therapy (HRT), and Endoscopy.

Paul Berkowitz is a Nephrologist practicing medicine in Ypsilanti, Michigan. Dr. Berkowitz is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Renovascular Hypertension, Nephrosclerosis, Chronic Kidney Disease, and Acute Tubular Necrosis.

Dr. Napolitano is Professor of Surgery at the University of Michigan School of Medicine, Acute Care Surgery (Trauma, Burns, Critical Care, Emergency Surgery), Program Director of the Surgical Critical Care Fellowship (6 fellows annually) and Associate Chair for the Department of Surgery. Dr. Napolitano is certified by the American Board of Surgery in General Surgery as well as Surgical Critical Care. She is a Fellow of the American College of Surgeons, American College of Critical Care Medicine (ACCM), and the American College of Chest Physicians. Dr. Napolitano is a member and holds leadership positions in numerous professional organizations in surgery, trauma and surgical critical care. Dr. Napolitano is Vice-Chancellor of the Board of Regents of the ACCM. She is past-Chair of the Surgical Section of the Society of Critical Care Medicine (SCCM), and was SCCM Congress Co-Chair in 2006. She served as Chair of the Committee on Perioperative Care for the American College of Surgeons (ACS) from 2003-2005. She is past-Chair of the Multi-Institutional Trials Committee and a member of the Board of Directors for the Eastern Association for the Surgery of Trauma and the Society for the Advancement of Blood Management. She is Secretary of the Surgical Infection Society. She is a member of the American Association for the Surgery of Trauma (AAST) Committee on Acute Care Surgery. She is a member of the Society of University Surgeons, Association of Women Surgeons, and American Surgical Association, among others. She participates nationally in many organizations, and is a member of the Surgical Education and Self-Assessment Program (SESAP) Committee of the ACS and a member of the Steering Committee of the ACS Fundamentals of Surgery Resident Curriculum Committee. She is a member of the national Surgical Care Improvement Project (SCIP) and CMS Technical Expert Panels for Respiratory and Infection, with the goal of reducing surgical complications by 25% by 2010. Dr. Napolitano received the 2002 Association of Women Surgeons Distinguished Member Award, awarded to a member that exemplifies the ideals and mission of the association. Other honors include Surgical Critical Care Educator of the Year Award (1998, 1999, 2000) from University of Maryland, and the Surgery Teacher of the Year Award in 1999 and 2001. She has been a mentor to a number of research fellows at the surgical resident and fellow level and her research group has received numerous awards, including the annual Resident Paper Competition of the ACS Committee on Trauma, SCCM Best Paper award, and numerous others. Dr. Napolitano has authored over 120 peer-reviewed publications, over 50 book chapters, and has been an invited lecturer at many national/international symposia and Visiting Professor at many institutions over the course of her career.Clinical Specialization:Dr. Napolitano's clinical interests are in the areas of general surgery, trauma and surgical critical care. Dr. Napolitano is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Gastrointestinal Fistula, Gastrointestinal Perforation, Appendectomy, and Gallbladder Removal. Dr. Napolitano is board certified in Surgery and Surgical Critical Care.

David Olson earned his M.D. and Ph.D. at the University of Michigan (the latter in Cellular and Molecular Biology). He served his internship and residency at Children’s Hospital Boston, followed by a fellowship in pediatric endocrinology and metabolism at Children’s Hospital Boston/Joslin Diabetes Center. Prior to returning to the University of Michigan, Dr. Olson was on staff at Children's Hospital Boston and affiliated with the Department of Newborn Medicine at Brigham and Women’s Hospital. His postdoctoral research was performed at Beth Israel Deaconess Medical Center, Division of Endocrinology. Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. Additional studies using neuron-specific genetic changes are underway to clarify the molecular basis of daily biologic rhythms and explore how disruption of these rhythms predisposes organisms (rodents and humans) to pathologic changes in metabolism. Dr. Olson is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS). Dr. Olson is board certified in Pediatric Endocrinology.

Brigid Gregg is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Gregg is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Obesity, Diabetes Insipidus (DI), and Neurohypophyseal Diabetes Insipidus.

Ram Menon is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Menon is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hypothyroidism, Short Stature (Growth Disorders), Pediatric Growth Hormone Deficiency, and Thyroidectomy. Dr. Menon is board certified in Pediatric Endocrinology.

Arqam Zia is an Endocrinologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 30 years. Dr. Zia is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Addison's Disease, Secondary Adrenal Insufficiency, and Triple A Syndrome. Dr. Zia is board certified in American Board Of Internal Medicine. Dr. Zia is currently accepting new patients.

Melda Ince is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Ince is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Congenital Generalized Lipodystrophy, Autosomal Dominant Hypocalcemia, Graves Disease, and Thyroid Storm.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.